Skip to content
In English |
En español
Search
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -3 of 3
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
9/1/2001
 
First Published:
7/1/2001
1.
Phase II Study of ZD0473 in Patients With Progressive or Relapsed Non-Small Cell Lung Cancer Who Have Failed First-Line Platinum-Based Chemotherapy (Summary Last Modified 09/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
NCI
UCLA-000307201A
ZENECA-0473IL/0003, NCI-G01-1974, NCT00021008
2.
Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
0402
IND No. 69,507, NCT00116610
Last Modified:
4/1/2002
 
First Published:
5/1/2001
3.
Phase I Study of ZD0473 and Doxorubicin HCl Liposome in Patients With Advanced Solid Tumors or Lymphoma (Summary Last Modified 04/2002)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Treatment
Closed
18 and over
NCI
MSKCC-00044
NCI-G01-1942, NCT00016172
Select All on One Page
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute